SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
APOP
--
0.00%
--
Cellect Biotechnology Q1 EPS $(0.002) Up From $(0.008) YoY
Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.00) per share. This is a 75 percent increase over losses of $(0.01) per share from the same period last year.
Benzinga · 05/21 20:19
84 Biggest Movers From Yesterday
Gainers
Benzinga · 05/13 09:31
60 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 05/12 16:26
Company News for May 12, 2020
Zacks · 05/12 15:09
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
GlobeNewswire · 05/12 13:48
GNFT, DT among premarket losers
Seeking Alpha - Article · 05/12 13:19
78 Biggest Movers From Yesterday
Gainers
Benzinga · 05/12 09:02
Mid-Afternoon Market Update: NASDAQ Rises Over 100 Points; Amneal Pharmaceuticals Shares Surge On Upbeat Results
Toward the end of trading Monday, the Dow traded down 0.11% to 24305.58 while the NASDAQ rose 1.17% to 9228. The S&P also rose, gaining 0.27% to 2,937.69.
Benzinga · 05/11 19:02
AMC, CYTK, MT and SALT among midday movers
Seeking Alpha - Article · 05/11 16:40
54 Stocks Moving In Monday's Mid-Day Session
Gainers
Benzinga · 05/11 16:39
Mid-Day Market Update: Recro Pharma Falls After Q1 Results; MyoKardia Shares Climb
Midway through trading Monday, the Dow traded down 0.80% to 24135.84 while the NASDAQ rose 0.19% to 9138.42. The S&P also fell, dropping 0.42% to 2917.35.
Benzinga · 05/11 16:29
Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) were advancing strongly Monday.
Benzinga · 05/11 15:46
Mid-Morning Market Update: Markets Mostly Lower; Cardinal Health Beats Q3 Estimates
Following the market opening Monday, the Dow traded down 0.83% to 24128.74 while the NASDAQ rose 0.19% to 9,138.91. The S&P also fell, dropping 0.52% to 2,914.59.
Benzinga · 05/11 14:15
CAH, BLUE among premarket gainers
Seeking Alpha - Article · 05/11 13:26
32 Stocks Moving in Monday's Pre-Market Session
Gainers
Benzinga · 05/11 11:18
Cellect Bio announces publication of ApoGraft data ahead of clinical trial
Seeking Alpha - Article · 05/11 10:33
Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process
Cellect Biotechnology Ltd.
Benzinga · 05/11 10:23
Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process
PR Newswire · 05/11 07:13
Cellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in Canada
PR Newswire · 04/27 15:19
AMRN, EPR among top gainers
Seeking Alpha - Article · 04/27 13:21